Denmark vs Sweden: Access to anti-retroviral drugs, male
Denmark
93.0%
in 2023
Sweden
95.0%
in 2022
Denmark rank
7th
Sweden rank
4th
Access to anti-retroviral drugs, male over time
- Denmark
- Sweden
How they compare
Sweden currently reports 95.0% against 93.0% in Denmark, a difference of 2.0%.
The two have swapped places 1 time across 23 shared years of data; in 2000 it was Denmark ahead.
Denmark ranks 7th and Sweden ranks 4th of 141 countries.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.4% | 53.7% | 4.3% | Sweden |
| 2010s | 77.6% | 92.5% | 14.9% | Sweden |
| 2020s | 90.7% | 95.3% | 4.7% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Denmark or Sweden?
- Sweden, at 95.0% against 93.0% in Denmark as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Denmark and Sweden?
- 2.0%, with Sweden ahead.
- How many years of comparable data are there for Denmark and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Denmark and Sweden rank globally for access to anti-retroviral drugs, male?
- Denmark ranks 7th and Sweden ranks 4th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.